Erythropoietin (EPO) attenuates the immunohistochemical expression of tumor growth factor-ß (TGF-ß) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats

D. Tsavlis (THESSALONIKI, Greece), D. Anestakis (THESSALONIKI, Greece), A. Tzoumaka (THESSALONIKI, Greece), C. Symeonidou (THESSALONIKI, Greece), K. Kouzi - Koliakou (THESSALONIKI, Greece), A. Tektonidou (THESSALONIKI, Greece), E. Spandou (THESSALONIKI, Greece)

Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Session: Pulmonary fibrosis: from models to patients
Session type: Thematic Poster
Number: 996
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Tsavlis (THESSALONIKI, Greece), D. Anestakis (THESSALONIKI, Greece), A. Tzoumaka (THESSALONIKI, Greece), C. Symeonidou (THESSALONIKI, Greece), K. Kouzi - Koliakou (THESSALONIKI, Greece), A. Tektonidou (THESSALONIKI, Greece), E. Spandou (THESSALONIKI, Greece). Erythropoietin (EPO) attenuates the immunohistochemical expression of tumor growth factor-ß (TGF-ß) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats. 996

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: